Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS
· Delayed Price · Currency is USD
30.48
+2.18 (7.70%)
At close: Jan 31, 2025
BIOVF Market Cap
BIOVF has a market cap or net worth of $10.08 billion as of February 21, 2025. Its market cap has increased by 10.85% in one year.
Market Cap
10.08B
Enterprise Value
11.55B
Revenue
2.35B
Ranking
n/a
PE Ratio
28.72
Stock Price
$30.48
Market Cap Chart
Since September 15, 2006, BIOVF's market cap has increased from 663.04M to 10.08B, an increase of 1,420.38%. That is a compound annual growth rate of 15.90%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 2.19B |
| SS Innovations International | 1.72B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 864.81M |
| Elite Pharmaceuticals | 520.73M |
| Glass House Brands | 497.07M |
| CytoDyn | 367.12M |
| Northwest Biotherapeutics | 326.95M |